Product NDC: | 24856-001 |
Proprietary Name: | JETREA |
Non Proprietary Name: | ocriplasmin |
Active Ingredient(s): | .5 mg/.2mL & nbsp; ocriplasmin |
Administration Route(s): | INTRAVITREAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24856-001 |
Labeler Name: | ThromboGenics Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125422 |
Marketing Category: | BLA |
Start Marketing Date: | 20121031 |
Package NDC: | 24856-001-00 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (24856-001-00) > .2 mL in 1 VIAL, SINGLE-USE |
NDC Code | 24856-001-00 |
Proprietary Name | JETREA |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (24856-001-00) > .2 mL in 1 VIAL, SINGLE-USE |
Product NDC | 24856-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ocriplasmin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVITREAL |
Start Marketing Date | 20121031 |
Marketing Category Name | BLA |
Labeler Name | ThromboGenics Inc. |
Substance Name | OCRIPLASMIN |
Strength Number | .5 |
Strength Unit | mg/.2mL |
Pharmaceutical Classes |